George Scangos, CEO of biotech powerhouse Biogen Idec, and David Page, director of MIT’s Whitehead Institute for Biomedical Research, have made a $5.3 million handshake, the Boston Globe reports, as the two institutions plan to collaborate on early-phase development.

…read more

Source: Biogen cozies up to MIT with a $5.3M drug discovery pact


0 No comments